The self testing market was valued at USD 27.7 billion in 2025, is projected to reach USD 52.7 billion by 2036 and is forecast to register a 6.1% CAGR between 2026 and 2036. In 2026, glucose monitoring holds 34.8% within the test type segment and blood-based tests represent 58.6% of the sample type category.